Security file · CUSIP 40637HAF6
HALOZYME THERAPEUTICS INC
HALOZYME THERAPEUTICS INC · held by 1 tracked manager in Q3 2024.
Tracked holders · Q3 2024
1
+0 vs Q2 2024
Aggregate reported value
$5.69M
sum of holders' reported positions
New holders this quarter
0
1 added · 0 trimmed
Holder return since filing
—
weighted by each holder's position share · since filing
Ownership · Q3 2024
| Manager | Weight | Shares | Δ shares | Entry | Return | Value | Activity | |
|---|---|---|---|---|---|---|---|---|
| 1 | Howard Marks - Oaktree Capital Managementfiled 14 Nov ET | 0.09% | 4.78M | +33.0% | — | — | $5.69M | Added |
Holder count
Aggregate reported value
Quarterly aggregation
| Quarter | Holders | Δ holders | Aggregate value | Total shares |
|---|---|---|---|---|
| Q3 2024 | 1 | +0 | $5.69M | 4.78M |
| Q2 2024 | 1 | +0 | $4.00M | 3.59M |
| Q4 2023 | 1 | +0 | $2.10M | 2.25M |
| Q3 2023 | 1 | — | $2.11M | 2.25M |